The Valley Desk

NCT02666248 · Observational study

Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-EGFRvIII Gene-modified Cellular Therapy Products in Cancer Studies

Overall registry status Completed

Conditions Subjects Entering Into This Protocol Will be Followed for up to 15 Years After Initial CART-EGFRvIII Infusion

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov